Literatura científica selecionada sobre o tema "Cancer de poumon"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Índice
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Cancer de poumon".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Cancer de poumon"
Chaleat, S., e L. Greillier. "Cancer du poumon". Revue des Maladies Respiratoires Actualités 11 (outubro de 2019): S29—S35. http://dx.doi.org/10.1016/s1877-1203(19)30161-2.
Texto completo da fonteBoucly, A., e B. Milleron. "Dépistage du cancer du poumon". Revue des Maladies Respiratoires Actualités 6, n.º 2 (maio de 2014): 115–17. http://dx.doi.org/10.1016/s1877-1203(14)70525-7.
Texto completo da fonteAntoni, D., e F. Mornex. "Cancer du poumon : « Les » radiothérapies". Revue des Maladies Respiratoires Actualités 8, n.º 5 (setembro de 2016): 332–40. http://dx.doi.org/10.1016/s1877-1203(16)30122-7.
Texto completo da fonteToffart, A. C., M. Giaj Levra, L. Ferrer, J. Pinsolle, N. Terzi e D. Moro-Sibilot. "Réanimation et cancer du poumon". Revue des Maladies Respiratoires Actualités 10, n.º 3 (outubro de 2018): 262–68. http://dx.doi.org/10.1016/s1877-1203(18)30019-3.
Texto completo da fonteRochon, Madeleine. "Tabagisme et cancer du poumon". Gérontologie et société 26 / n° 105, n.º 2 (2003): 69. http://dx.doi.org/10.3917/gs.105.0069.
Texto completo da fonteLüthi, François, Christian Monnerat, Roger Stupp, Hans-Beat Ris, Abderrrahim Zouhair e Thomas McKee. "Cancer du poumon : portrait 2004". Revue Médicale Suisse 62, n.º 2477 (2004): 776–82. http://dx.doi.org/10.53738/revmed.2004.62.2477.0776.
Texto completo da fonteMilleron, B., S. Couraud, E. Grolleau e V. Gounant. "Le dépistage du cancer du poumon". Revue des Maladies Respiratoires Actualités 14, n.º 2 (outubro de 2022): 2S37–2S41. http://dx.doi.org/10.1016/s1877-1203(22)00098-2.
Texto completo da fonteGrolleau, E., M. Darrason, J. de Bermont, B. Milleron e S. Couraud. "Le dépistage du cancer du poumon". Revue des Maladies Respiratoires Actualités 13, n.º 2 (setembro de 2021): 2S21–2S25. http://dx.doi.org/10.1016/s1877-1203(21)00092-6.
Texto completo da fonteMilleron, B., V. Gounant, A. Khalil e S. Couraud. "Le dépistage du cancer du poumon". Revue de Pneumologie Clinique 73, n.º 1 (fevereiro de 2017): 27–33. http://dx.doi.org/10.1016/j.pneumo.2016.10.002.
Texto completo da fontePerez, Noemí Busquets, Berta Bernad, Javier Narváez e José Valverde. "Érythème noueux et cancer du poumon". Revue du Rhumatisme 73, n.º 5 (maio de 2006): 525–26. http://dx.doi.org/10.1016/j.rhum.2005.06.011.
Texto completo da fonteTeses / dissertações sobre o assunto "Cancer de poumon"
Meary, Alexandre. "Schizophrenie et cancer du poumon". Paris 6, 2001. http://www.theses.fr/2001PA062055.
Texto completo da fonteBenizri, Emmanuel. "HIF-1alpha : le poumon du cancer". Nice, 2007. http://www.theses.fr/2007NICE4044.
Texto completo da fonteAny alive organism can survive without energy, which involves a satisfactory oxygen and nutriments supply. At the initial phase of tumor progression, cells proliferate without their own vascularization ; indeed, oxygen and nutrients are delivered by simple diffusion. Nevertheless, beyond a certain size, these mechanisms are no more effective and oxygen deficiencies appear. The transcription factor HIF (Hypoxia Inducible Factor) is a key regulator required to maintain oxygen homeostasis. HIF is composed of a constitutive HIF-â sub-unit and a HIF- 1á sub-unit, specific of the hypoxic cascade. Three hifá genes have been identified : hif1a, epas 1 and hif3a that code for HIF-1á, HIF-2á and HIF-3á, respectively. Because of its ubiquitous tissue distribution and its central impact on the regulation of the target genes, HIF- 1á is the mosty studied isoform. During my laboratory training, I have contributed to 3 main projects : • First, I have been focused on the regulatory mechanisms that control HIF-1á stability and more precisely, on the study of the HIF prolyl-hydroxylase (PHDs). Using a RNA interference (RNAi) approach, we have highlighted PHD2 as the key isoform that controls HIF-1á stability in normoxia. Related to clinical studies, we have evaluated the impact of HIF-1á immunostaining in a serie of breast cancer. We have shown that HIF-1á is an independent prognostic factor and a bad preditive factor for classical adjuvant treatments. • Finally, in a pre-clinical study, we have analyzed the impact of HIF-1á invalidation by RNAi in a xenograft melanoma model. We have reported a reduction of tumor growth in mice treated with siRNAs targeting HIF-1á
Michel, Noémie. "Analyse de la contribution des kallicréines tissulaires 6 et 12 à la physiopathologie pulmonaire". Thesis, Tours, 2013. http://www.theses.fr/2013TOUR3303/document.
Texto completo da fonteRecently, human tissue kallikreins (KLK) emerged as a new family of serine proteases which might play a major role in the tumorigenesis. The project aims at determining the contribution of KLK6 and 12 in lung pathophysiology. We showed that ectopic KLK6 promoted A549 cell proliferation in a protease activity-dependant manner, inhibited cell apoptosis and induced β-catenin nuclear translocation. Furthermore, this study uncovered a signaling pathway mediated by KLK6 in promoting A549 cell proliferation trough activation of the PAR2-EGFR-ERK pathway.We have also identified novel substrates of KLK12, the CCN family. We reported that KLK12-mediated proteolysis of CCN1 and CCN5 can reduce or abolish the binding of VEGF, BMP2, and TGF-β1
Pardo, Olivier. "Thérapie génique du cancer du poumon par la HSP65". Paris 5, 1997. http://www.theses.fr/1997PA05P120.
Texto completo da fonteDerniame, Sophie. "Cancer du poumon / Réponse immunitaire locale - modulation tumeur dépendante". Nancy 1, 2006. http://docnum.univ-lorraine.fr/public/SCD_T_2006_0097_DERNIAME.pdf.
Texto completo da fonteLung cancer is the most frequent type of cancer in the world. Smoking is clearly the major cause of this pathology. The proliferation of tumor cells induces an inflammatory stromal reaction comprising numerous tumor-infiltrating lymphocytes. In this study, four complementary approaches have been used to study the tumor-dependent modulation of the immune system : TCR Vβ repertoire usage in flow cytometry, TCRγ gene clonal rearrangements in denaturing gradient gel electrophoresis (DGGE/TTGE), tumor and healthy lung tissue infiltration as well as lymph nodes characteristics in immunohistology and cytokine production by RNA RT-PCR. The results obtained have demonstrated the oligoclonality of T-cells in the three types of tissues tested. A Vβ13. 1 clone and a gamma clone appeared to be specifics of epidermoid carcinoma. Similarly, two TCRγ clones appeared to be restricted to adenocarcinoma. Moreover, the CD3/TCR complex was clearly down regulated in tumors compared to healthy tissue or lymph nodes. Similarly, HLA-DR, HLA-DQ and β2 microglobuline, strongly expressed on healthy pneumocytes were nearly absent from tumor cells. Several cytokines with antagonistic effects were detected within tumoral tissue, especially TGFβ and IL-10, which favour tumor growth and TNFalpha and IFNγ which potentialize the anti-tumoral immune response. In conclusion, the clones identified in healthy lung tissue could be specific of early pre-tumoral lesions induced by tobacco smoke, and some of the clones appear to be tumor-specific. However, the immune system has been defeated by several mechanisms, including a decrease of the expression of partners of the immunological synapse and the production of antagonistic cytokines
CAILLET, BRUNO. "Genetique et cancer du poumon : interet des etudes familiales". Lyon 1, 1991. http://www.theses.fr/1991LYO1M273.
Texto completo da fonteSève, Pascal. "Pharmacorésistance et cancer du poumon Non à petites cellules". Lyon 1, 2006. http://www.theses.fr/2006LYO10008.
Texto completo da fonteCauchi, Stéphane. "Etude des polymorphismes génétiques du récepteur aux hydrocarbures polycycliques aromatiques (AHR) et de son répresseur (AHRR) : relation avec l'inductibilité du CYP1A1 et le cancer pulmonaire". Paris 5, 2003. http://www.theses.fr/2003PA05N030.
Texto completo da fontePolycyclic aromatic hydrocarbons (PAH) found in cigarette smoke play a key role in the appearance of the lung cancer at the smokers. Cytochrome P-4501A1, metabolizes these HPA like benzo(a)pyrene in reactive and mutagen compounds. The CYP1A1 is inductible by the HPA and others compounds like dioxine. This inductibility is itself variable and largely dependent on the receptor Ah (AhR). The AhR is partially responsible for a polymorphic expression of the CYP1A1 and thus could be an important factor in carcinogenicity. We investigated the genetic polymorphisms of the AhR gene in a case-control study of lung cancer. Two new polymorphisms were found, none of them were found to play a key role. . .
RUGGIERI, SOPHIE. "Traitement des cancers du poumon non anaplasiques, non resecables, non metastatiques : a propos de 505 cas". Angers, 1989. http://www.theses.fr/1989ANGE1084.
Texto completo da fonteTLEMSANI, LARBI. "Prise en charge du cancer du poumon au centre hospitalier general de cahors de 1989 a 1992". Toulouse 3, 1993. http://www.theses.fr/1993TOU31084.
Texto completo da fonteLivros sobre o assunto "Cancer de poumon"
Trédaniel, Jean. Le cancer du poumon. Paris: Masson, 2004.
Encontre o texto completo da fonteLaboratoire de lutte contre la maladie (Canada). Bureau du cancer. Le cancer du poumon au Canada. Ottawa, Ont: Santé Canada, 1998.
Encontre o texto completo da fonteLitt, Claudia. J'ai le cancer, et alors? Lyon: Chronique sociale, 2012.
Encontre o texto completo da fonteGiovanni, Motta, e Agrigento International Conference on Imaging and Therapy of Lung Cancer. (1st : 1988), eds. Lung cancer: Advanced concepts and present status. Genoa: Grafica, L.P., 1989.
Encontre o texto completo da fonteMackay, Bruce. Tumors of the lung. Philadelphia: W.B. Saunders, 1991.
Encontre o texto completo da fonteLemonde, Manon. Qualité de vie de personnes atteintes de cancer du poumon avancé. Montréal, Qué: Université de Montréal, 1999.
Encontre o texto completo da fonteStap, Sophie van der. La fille aux neuf perruques: Témoignage. [Paris]: Presses de la Cité, 2009.
Encontre o texto completo da fonteMayer, Carole R. Les directives avancées à l'usage des patients atteints du cancer du poumon. Sudbury, Ont: École de Service Social, Université Laurentienne, 1996.
Encontre o texto completo da fonteStatistique Canada. Direction des études analytiques. Utilisation de POHEM pour l'estimation des coûts médicaux directs associés à la pratique actuelle du traitement du cancer du poumon ainsi que pour l'évaluation économique de nouveaux traitements. Ottawa, Ont: Statistique Canada, 1997.
Encontre o texto completo da fonteNATO Advanced Research Workshop on Mechanisms in Fibre Carcinogenesis (1990 Albuquerque, N.M.). Mechanisms in fibre carcinogenesis. New York: Plenum Press, 1991.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "Cancer de poumon"
Molinié, F., A. Danzon, G. Hédelin e E. A. Sauleau. "Poumon". In Survie des patients atteints de cancer en France, 185–92. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-39310-5_25.
Texto completo da fonteLozano, S., e J. Mazières. "Le cancer du poumon du sujet âgé". In Oncogériatrie, 79–84. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-8178-0142-1_12.
Texto completo da fonteDauchy, S., e C. Lopez. "Prise en charge psychologique du patient atteint de cancer du poumon". In Oncologie thoracique, 367–78. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-287-99041-0_24.
Texto completo da fonteSocinski, Mark A. "Cancer du poumon". In Médecine interne de Netter, 609–16. Elsevier, 2011. http://dx.doi.org/10.1016/b978-2-294-70951-7.00078-5.
Texto completo da fonte"Cancers du poumon". In Méga Guide STAGES IFSI, 89–97. Elsevier, 2015. http://dx.doi.org/10.1016/b978-2-294-74529-4.00022-7.
Texto completo da fonteAlexandre, J., A. Balian, L. Bensoussan, A. Chaïb, G. Gridel, K. Kinugawa, F. Lamazou et al. "Cancers du poumon". In Le tout en un révisions IFSI, 82–89. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-294-70633-2.50022-6.
Texto completo da fonteALLIO, I., A. M. DEMARTINI, J. J. MENEC, V. CARDE e V. TREGUER-HERROU. "Le dépistage par le Laboratoire d’analyses, de surveillance et d’expertise de la Marine de Brest du radon, un gaz radioactif naturel en Bretagne". In Médecine et Armées Vol. 44 No.4, 309–16. Editions des archives contemporaines, 2016. http://dx.doi.org/10.17184/eac.6820.
Texto completo da fonteTaber, Douglass. "Alkaloid Synthesis: Crispine A (Zhou), Cermizine C (Zhang), Tangutorine (Poupon), FR901483 (Kerr), Serratezomine A (Johnston)". In Organic Synthesis. Oxford University Press, 2011. http://dx.doi.org/10.1093/oso/9780199764549.003.0061.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Cancer de poumon"
Dias, Andrey Luis de Oliveira Gonçalves, Thaíz da Silva Gome e Leila Cristina Soares Brollo. "Câncer de endométrio associado a radiação pélvica prévia paratratamento de câncer de colo uterino: relato de caso". In 45º Congresso da SGORJ XXIV Trocando Ideias. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/jbg-0368-1416-20211311018.
Texto completo da fonteMacedo, Aruan Kawally Coutinho De, Felipe De Andrade Moreira, Fernanda Clara Marinheiro Oliveira e Neidivania Medeiros Da Nobrega. "O DIAGNÓSTICO PRECOCE DA LEUCEMIA MIELOIDE AGUDA". In II Congresso Brasileiro de Hematologia Clínico-laboratorial On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/hematoclil/10.
Texto completo da fonte